As the popularity of GLP-1 receptor agonists, such as Ozempic, continues to grow, medical professionals are shifting their focus toward the long-term nutritional consequences of these medications. Because these drugs function by suppressing appetite and slowing gastric emptying, patients often consume significantly fewer calories than they did previously. Experts warn that this drastic reduction in food intake can inadvertently lead to deficiencies in essential nutrients, specifically protein and vitamin D.

While the primary goal of these treatments is weight loss, clinicians emphasize that the quality of food consumed remains critical. When patients eat less, every calorie becomes more important; if a patient is not intentional about their dietary choices, they may fail to meet the minimum requirements for muscle maintenance and bone health. Some medical providers are now recommending that patients work closely with dietitians or nutritionists to ensure they are prioritizing nutrient-dense foods while on the medication. There is currently no consensus on whether universal supplementation is required, but the medical community is increasingly advocating for routine blood work to monitor for potential deficits as patients progress through their weight-loss journeys.